Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00000604
DRKS00000604
Not yet recruiting
未知

Effects of oxytocin on patients with Borderline Personality Disorder

Psychologisches Institut der Albert-Ludwigs-Universität FreiburgAbteilung für Biologische und Differentielle Psychologie0 sites250 target enrollmentNovember 19, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsF60.31F33.1Recurrent depressive disorder, current episode moderate

Overview

Phase
未知
Intervention
Not specified
Conditions
F60.31
Sponsor
Psychologisches Institut der Albert-Ludwigs-Universität FreiburgAbteilung für Biologische und Differentielle Psychologie
Enrollment
250
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2010
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Psychologisches Institut der Albert-Ludwigs-Universität FreiburgAbteilung für Biologische und Differentielle Psychologie

Eligibility Criteria

Inclusion Criteria

  • •Borderline personality disorder or major depression (clinical control group)
  • •\- 18 \- 50 years of age
  • •\- Mini Mental Status Test \> 27 (capacity to consent)

Exclusion Criteria

  • •\- chronic or acute somatic health problems
  • •\- Schizophrenia
  • •\- Bipolar affective disorder
  • •\- pregnancy
  • •\- breast feeding
  • •\- neurological disorder
  • •\- allergy to antidegradants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
sing oxytocin in individuals with body dysmorphic disorder (BDD)Body Dysmorphic DisorderMental Health - Other mental health disorders
ACTRN12622000429752Swinburne University of Technology46
Not yet recruiting
Not Applicable
Relationship between oxytocin and borderline personality disorderMental DisordersBorderline Personality DisorderF03.675.100
RBR-2rnbw6Faculdade de Medicina de Ribeirão Preto
Not yet recruiting
Phase 4
Evaluation of the effects of oxytocin in patients with schizophreniaSchizophreniaObesityHealthy volunteersM01.774.500
RBR-4yr9mtFaculdade de Medicina de Ribeirão Preto
Active, not recruiting
Phase 1
group-therapy, autism and oxytocin - an investigation with the question Does oxytocin (OT) enhance therapy effects in autism?
EUCTR2010-024202-34-DEIVERSITÄTSMEDIZIN GÖTTINGEN, GEORG-AUGUST-UNIVERSITÄT,Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie210
Recruiting
Not Applicable
Evaluation of oxytocin treatment in children with autism and intellectual disability’, Multiple-dose Oxytocine - ASD and Intellectual Disability
2024-513436-14-00UZ Leuven80